Xeris Biopharma Holdings, Inc. (XERS)

Revenue & Top-Line Growth

Latest Revenue

$83.1M

Financial Fundamentals

XERS • Quarterly Data • 5Y View

Date	Revenue ($B)	QoQ %	YoY %	TTM ($B)	TTM %
2026-03-31	0.08B	-3.1%	+38.3%	0.31B	+41.5%
2025-12-31	0.09B	+15.4%	+42.8%	0.29B	+43.7%
2025-09-30	0.07B	+4.0%	+37.1%	0.27B	+42.0%
2025-06-30	0.07B	+19.0%	+48.8%	0.25B	+35.6%
2025-03-31	0.06B	+0.0%	+47.9%	0.22B	+29.9%
2024-12-31	0.06B	+10.7%	+35.4%	0.20B	+23.9%
2024-09-30	0.05B	+12.9%	+12.3%	0.19B	+22.7%
2024-06-30	0.05B	+18.3%	+26.5%	0.18B	+35.3%
2024-03-31	0.04B	-8.5%	+22.4%	0.17B	+41.2%
2023-12-31	0.04B	-8.1%	+33.9%	0.16B	+48.7%
2023-09-30	0.05B	+27.1%	+62.6%	0.15B	+54.6%
2023-06-30	0.04B	+14.5%	+50.2%	0.13B	+67.4%
2023-03-31	0.03B	+0.2%	+50.4%	0.12B	+90.6%
2022-12-31	0.03B	+11.5%	+53.0%	0.11B	+121.4%
2022-09-30	0.03B	+17.5%	+169.4%	0.10B	+179.7%
2022-06-30	0.03B	+14.6%	+184.1%	0.08B	+137.5%
2022-03-31	0.02B	+1.9%	+169.3%	0.06B	+137.3%
2021-12-31	0.02B	+96.4%	+202.1%	0.05B	+143.7%
2021-09-30	0.01B	+23.9%	+16.8%	0.04B	+133.4%
2021-06-30	0.01B	+8.7%	+339.4%	0.03B	+461.8%
2021-03-31	0.01B	+14.3%	+358.3%	0.03B	+525.0%
2020-12-31	0.01B	-24.1%	+284.8%	0.02B	+641.7%
2020-09-30	0.01B	+366.1%	+2825.1%	0.02B	+794.0%
2020-06-30	0.00B	+13.4%	+533.4%	0.01B	+207.6%
2020-03-31	0.00B	-4.1%	+621.0%	0.00B	+75.3%
2019-12-31	0.00B	+477.1%	+132.7%	0.00B	+11.8%
2019-09-30	0.00B	+0.9%	-44.5%	0.00B	-20.6%
2019-06-30	0.00B	+29.0%	-60.9%	0.00B	+13.5%
2019-03-31	0.00B	-69.0%	-5.7%	0.00B	+67.2%
2018-12-31	0.00B	+37.6%	+71.5%	0.00B	+58.4%
2018-09-30	0.00B	-28.9%	+242.4%	0.00B	—
2018-06-30	0.00B	+211.4%	+45.0%	0.00B	—
2018-03-31	0.00B	-43.7%	-25.7%	0.00B	—
2017-12-31	0.00B	+174.7%	—	0.00B	—
2017-09-30	0.00B	-69.9%	—	0.00B	—
2017-06-30	0.00B	+59.6%	—	0.00B	—
2017-03-31	0.00B	—	—	0.00B	—